JPMorgan CEO Jamie Dimon Says ‘Powerful Forces’ Threaten U.S. Economy
While the bank CEO said the U.S. economy is growing, the company socked away funds to prepare for higher defaults in case of a recession, and its first-quarter profit fell 42%. #recession #bankceo #jpmorgan #jamiedimon #powerfulforces (Source: Reuters: Health)
Source: Reuters: Health - April 13, 2022 Category: Consumer Health News Source Type: news

Delta says hiking fares can help it can turn a profit as fuel costs surge
Travel is booming, and Delta Air Lines boosted ticket prices. That helped the company weather higher fuel costs in the first quarter, and Delta believes it can turn a profit in the second quarter. (Source: Reuters: Health)
Source: Reuters: Health - April 13, 2022 Category: Consumer Health News Source Type: news

JPMorgan Profit Sinks 42% After a Pandemic Boom
The bank’s quarterly profit fell to $8.28 billion, weighed down by lower Wall Street fees and higher expenses. (Source: Reuters: Health)
Source: Reuters: Health - April 13, 2022 Category: Consumer Health News Source Type: news

Delta forecasts a quarterly profit as travelers keep flying despite higher fares, helping offset surging fuel costs
Delta said it expects a pretax profit in the second quarter and that it will restore capacity to 84% of 2019 levels. (Source: Reuters: Health)
Source: Reuters: Health - April 13, 2022 Category: Consumer Health News Source Type: news

Ohio State Buckeyes to honor legacy of late quarterback Dwayne Haskins at spring game
Ohio State will honor former quarterback Dwayne Haskins at Saturday's spring game, as the football program grieves the loss of a record-setting player who coach Ryan Day said brought compassion... #springgame #ohiostatebuckeyes #lockerroom #quarterback #ryanday #dwaynehaskins (Source: Reuters: Health)
Source: Reuters: Health - April 11, 2022 Category: Consumer Health News Source Type: news

Steelers Quarterback Dwayne Haskins Killed in Auto Accident
Pittsburgh Steelers quarterback Dwayne Haskins was killed in an auto accident Saturday in Florida. Haskins’ agent, Cedric Saunders, told ESPN about the quarterback’s death, and the Steelers released a statement extending their condolences. “I am devastated and at a loss for words with the unfortunate passing of Dwayne Haskins,” Steelers coach Mike Tomlin said. “He quickly became part of our Steelers family upon his arrival in Pittsburgh and was one of our hardest workers, both on the field and in our community. Dwayne was a great teammate, but even more so a tremendous friend to so many. I am ...
Source: TIME: Science - April 9, 2022 Category: Science Authors: Time Tags: Uncategorized Source Type: news

The Connection Between IBD and Aging
Inflammatory bowel disease (IBD) has long been thought of as an ailment of middle, or even young, adulthood. The chronic illness—which includes Crohn’s disease and ulcerative colitis, and can cause abdominal pain, diarrhea, bleeding, and decreased quality of life—impacts about 3.1 million people in the U.S. However, it is far from a disease only of the young and middle-aged. More than a quarter of people with IBD are elderly, a figure that is projected to climb to 30% by 2030, according to a 2021 Gastroenterology & Hepatology article. Even more underappreciated is the growing population of people who ...
Source: TIME: Health - April 8, 2022 Category: Consumer Health News Authors: Katherine Harmon Courage Tags: Uncategorized Disease healthscienceclimate Source Type: news

Nanox reports increased revenue for Q4 2021
Nanox reported $1.3 million in revenue for the fourth quarter of the 202...Read more on AuntMinnie.comRelated Reading: Nanox announces CPT code for use with for CAC AI software Nanox reports higher net loss in Q3 Nanox wraps up Zebra, USARad acquisitions Nanox adds distributor for South America Nanox hit with shareholder lawsuits after stock drop (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 1, 2022 Category: Radiology Source Type: news

The Age of the Private Space Station Is Upon Us
It was all smiles and thumbs-up on March 30, at 5:28 PM local time, when NASA astronaut Mark Vande Hei and Russian cosmonauts Anton Shkaplerov and Pyotr Dubrov thumped down in the steppes of Kazakhstan aboard a Russian Soyuz spacecraft—and with good reason. For one thing, Vande Hei had just completed a marathon 355 consecutive days aboard the International Space Station (ISS), setting a new U.S. space endurance record. For another—more important—thing, the joint U.S.-Russian return to Earth was one of the rare exercises in cooperation between the two nations during the white-hot tension between Washington...
Source: TIME: Science - April 1, 2022 Category: Science Authors: Jeffrey Kluger Tags: Uncategorized healthscienceclimate Space Source Type: news

Data from New VOYAGER PAD Analyses at ACC.22 Reinforce Benefit of XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Peripheral Artery Disease (PAD) and Various Co-Morbid Conditions
RARITAN, N.J., April 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from new analyses from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefit of the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) in reducing severe vascular events in patients with PAD after lower-extremity revascularization (LER), a procedure that restores blood flow to the legs. Data from the two analyses demonstrate the role that the XARELTO® vascular dose plays in PAD patients with and without chronic kidney disease (CKD) and in PAD patients with and ...
Source: Johnson and Johnson - April 1, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Walgreens Profits Hit $883 Million On Strong Covid Testing And Vaccine Demand
Walgreens Boots Alliance reported more than $880 million in quarterly profits as customers continued to get vaccinated and boosted against Covid-19. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 31, 2022 Category: Pharmaceuticals Authors: Bruce Japsen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma Source Type: news

BioNTech's quarterly profit soars on COVID-19 vaccine demand
BioNTech has reported another quarter of strong earnings growth (Source: ABC News: Health)
Source: ABC News: Health - March 30, 2022 Category: Consumer Health News Tags: Health Source Type: news

U.S. FDA Approves CABENUVA (cabotegravir and rilpivirine) for Adolescents, Expanding the Indication of the First and Only Complete Long-Acting Injectable HIV Regimen
TITUSVILLE, N.J., March 29, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved CABENUVA (cabotegravir and rilpivirine) for the treatment of HIV-1 in virologically suppressed adolescents (HIV-1 RNA less than 50 copies per milliliter [c/mL]) who are 12 years of age or older, weigh at least 35 kg and are on a stable antiretroviral regimen, with no history of treatment failure, nor known or suspected resistance to either cabotegravir or rilpivirine.1,2 Co-developed as part of a collaboration with ViiV Healthcare, CABENUVA is the first ...
Source: Johnson and Johnson - March 30, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

New Orleans Pelicans rally from 23 down, deal Los Angeles Lakers tough loss in key game in West
Thanks to a 41-point third quarter, the Pelicans stunned the Lakers 116-108 in a pivotal contest in the Western Conference play-in race. #losangeleslakers #pelicans #westernconference (Source: Reuters: Health)
Source: Reuters: Health - March 28, 2022 Category: Consumer Health News Source Type: news

New Data Show Majority of Adults with Moderate to Severe Plaque Psoriasis Treated with First-in-Class TREMFYA ® (guselkumab) Experienced Durable Skin Clearance Through Five Years Regardless of Metabolic Syndrome Status, Baseline Disease Severity, or Treatment History
SPRING HOUSE, PENNSYLVANIA, March 25, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced its first-in-class interleukin (IL)-23 inhibitor TREMFYA® (guselkumab) provided a consistent, high degree of durable skin clearance through five years in a majority of adult patients across broad subpopulations with moderate to severe plaque psoriasis (PsO) in the Phase 3 VOYAGE 1 and VOYAGE 2 clinical trials.1 A separate post hoc analysis of the VOYAGE studies showed TREMFYA provided high rates of efficacy and durability through five years and similar safety outcomes among patients with and without...
Source: Johnson and Johnson - March 25, 2022 Category: Pharmaceuticals Source Type: news